BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11242843)

  • 21. Concern about the use of venlafaxine to treat vasomotor symptoms--reply.
    Joffe H; LaCroix AZ; Cohen L
    JAMA Intern Med; 2015 Apr; 175(4):658-9. PubMed ID: 25844753
    [No Abstract]   [Full Text] [Related]  

  • 22. Paroxetine (Brisdelle) for hot flashes.
    Med Lett Drugs Ther; 2013 Oct; 55(1428):85-6. PubMed ID: 24165707
    [No Abstract]   [Full Text] [Related]  

  • 23. Venlafaxine alters microvascular perfusion, [¹²³I]-beta-CIT binding and BDI scores in flushing postmenopausal women.
    Sassarini J; Krishnadas R; Cavanagh J; Nicol A; Pimlott SL; Ferrell W; Lumsden MA
    Maturitas; 2014 Mar; 77(3):267-73. PubMed ID: 24411555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desvenlafaxine: a therapeutic option for treatment of menopausal hot flashes.
    Archer DF
    Maturitas; 2010 May; 66(1):1-2. PubMed ID: 20211532
    [No Abstract]   [Full Text] [Related]  

  • 25. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.
    Stearns V; Isaacs C; Rowland J; Crawford J; Ellis MJ; Kramer R; Lawrence W; Hanfelt JJ; Hayes DF
    Ann Oncol; 2000 Jan; 11(1):17-22. PubMed ID: 10690382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
    Albertazzi P
    J Br Menopause Soc; 2006 Mar; 12(1):7-11. PubMed ID: 16513016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug treatment for resistant depression.
    Daniels S
    Br J Psychiatry; 2000 Apr; 176():398. PubMed ID: 10827893
    [No Abstract]   [Full Text] [Related]  

  • 28. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
    Joffe H; Guthrie KA; LaCroix AZ; Reed SD; Ensrud KE; Manson JE; Newton KM; Freeman EW; Anderson GL; Larson JC; Hunt J; Shifren J; Rexrode KM; Caan B; Sternfeld B; Carpenter JS; Cohen L
    JAMA Intern Med; 2014 Jul; 174(7):1058-66. PubMed ID: 24861828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonestrogenic management of hot flashes.
    Loprinzi CL; Barton DL; Qin R
    J Clin Oncol; 2011 Oct; 29(29):3842-6. PubMed ID: 21911722
    [No Abstract]   [Full Text] [Related]  

  • 30. Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer.
    Vitolins MZ; Griffin L; Tomlinson WV; Vuky J; Adams PT; Moose D; Frizzell B; Lesser GJ; Naughton M; Radford JE; Shaw EG
    J Clin Oncol; 2013 Nov; 31(32):4092-8. PubMed ID: 24081940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of menopausal hot flashes.
    Tong IL
    Med Health R I; 2008 Mar; 91(3):73-6. PubMed ID: 18438096
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical Inquiry: Do venlafaxine and gabapentin control hot flashes in women with a history of breast cancer?
    Sarkissian A; Neher JO; Singh R; St Anna L
    J Fam Pract; 2012 Dec; 61(12):759-72. PubMed ID: 23313996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [ Hot flashes and breast cancer: what to do? ].
    Aldrighi JM; Ribeiro AL; Aoki T
    Rev Assoc Med Bras (1992); 2008; 54(5):381-2. PubMed ID: 18989552
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.
    Evans ML; Pritts E; Vittinghoff E; McClish K; Morgan KS; Jaffe RB
    Obstet Gynecol; 2005 Jan; 105(1):161-6. PubMed ID: 15625158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin reuptake inhibitors in Raynaud's phenomenon.
    Jaffe IA
    Lancet; 1995 May; 345(8961):1378. PubMed ID: 7752794
    [No Abstract]   [Full Text] [Related]  

  • 36. Venlafaxine in somatopsychic and autopsychic depersonalization.
    Preve M; Mula M; Cassano GB; Pini S
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1808-9. PubMed ID: 21740948
    [No Abstract]   [Full Text] [Related]  

  • 37. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial.
    Stearns V; Slack R; Greep N; Henry-Tilman R; Osborne M; Bunnell C; Ullmer L; Gallagher A; Cullen J; Gehan E; Hayes DF; Isaacs C
    J Clin Oncol; 2005 Oct; 23(28):6919-30. PubMed ID: 16192581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilot evaluation of paroxetine for treating hot flashes in men.
    Loprinzi CL; Barton DL; Carpenter LA; Sloan JA; Novotny PJ; Gettman MT; Christensen BJ
    Mayo Clin Proc; 2004 Oct; 79(10):1247-51. PubMed ID: 15473404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Inquiry: Which nonhormonal treatments are effective for hot flashes?
    Kelsberg G; Maragh L; Safranek S
    J Fam Pract; 2016 May; 65(5):E1-3. PubMed ID: 27275942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDA approval of paroxetine for menopausal hot flushes.
    Orleans RJ; Li L; Kim MJ; Guo J; Sobhan M; Soule L; Joffe HV
    N Engl J Med; 2014 May; 370(19):1777-9. PubMed ID: 24806158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.